×
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
S&P 500   3,820.84 (+0.94%)
DOW   31,064.50 (+0.94%)
QQQ   282.25 (+0.70%)
AAPL   138.68 (+1.43%)
MSFT   259.68 (+1.11%)
META   159.87 (-0.86%)
GOOGL   2,174.54 (-0.22%)
AMZN   109.61 (+3.20%)
TSLA   679.75 (+0.94%)
NVDA   145.26 (-4.18%)
NIO   21.40 (-1.47%)
BABA   116.08 (+2.11%)
AMD   73.75 (-3.56%)
MU   53.62 (-3.00%)
CGC   2.82 (-1.05%)
T   21.36 (+1.91%)
GE   63.81 (+0.22%)
F   11.31 (+1.62%)
DIS   96.18 (+1.89%)
AMC   13.47 (-0.59%)
PFE   52.32 (-0.21%)
PYPL   71.46 (+2.32%)
NFLX   179.97 (+2.92%)
NYSE:A

Agilent Technologies Stock Forecast, Price & News

$119.43
+0.66 (+0.56%)
(As of 07/1/2022 03:38 PM ET)
Add
Compare
Today's Range
$116.70
$119.71
50-Day Range
$112.71
$130.55
52-Week Range
$112.52
$179.57
Volume
35,957 shs
Average Volume
2.04 million shs
Market Capitalization
$35.67 billion
P/E Ratio
28.78
Dividend Yield
0.71%
Price Target
$159.91
30 days | 90 days | 365 days | Advanced Chart

Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Stock Forecast (MarketRank)

Overall MarketRank

3.19 out of 5 stars

Computer And Technology Sector

38th out of 937 stocks

Analytical Instruments Industry

1st out of 33 stocks

Analyst Opinion: 4.4Community Rank: 4.9Dividend Strength: 3.3Insider Behavior: 0.8Valuation: 2.5 5 -4 -3 -2 -1 -
Agilent Technologies logo

About Agilent Technologies (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
17,000
Year Founded
1999

Company Calendar

Ex-Dividend for 4/27 Dividend
4/04/2022
Dividend Payable
4/27/2022
Last Earnings
5/24/2022
Today
7/01/2022
Ex-Dividend for 7/27 Dividend
7/01/2022
Dividend Payable
7/27/2022
Next Earnings (Estimated)
8/16/2022
Fiscal Year End
10/31/2022

Price Target and Rating

Average Stock Price Forecast
$159.91
High Stock Price Forecast
$185.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
+33.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Net Income
$1.21 billion
Pretax Margin
21.86%

Debt

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$5.39 per share
Book Value
$17.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$35.67 billion
Optionable
Optionable
Beta
1.05

Social Links















Agilent Technologies Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2022?

12 Wall Street research analysts have issued 12 month price targets for Agilent Technologies' stock. Their A stock forecasts range from $130.00 to $185.00. On average, they expect Agilent Technologies' stock price to reach $159.91 in the next twelve months. This suggests a possible upside of 33.9% from the stock's current price.
View analysts' price targets for Agilent Technologies
or view top-rated stocks among Wall Street analysts.

How has Agilent Technologies' stock performed in 2022?

Agilent Technologies' stock was trading at $159.65 at the beginning of the year. Since then, A shares have decreased by 25.2% and is now trading at $119.43.
View the best growth stocks for 2022 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 2,880,000 shares, a decrease of 18.9% from the May 15th total of 3,550,000 shares. Based on an average daily volume of 1,970,000 shares, the short-interest ratio is currently 1.5 days. Currently, 1.0% of the company's stock are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 16th 2022.
View our earnings forecast for Agilent Technologies
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Tuesday, May, 24th. The medical research company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.01. The medical research company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a trailing twelve-month return on equity of 27.42% and a net margin of 19.35%. The business's revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.97 earnings per share.
View Agilent Technologies' earnings history
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, May 18th. Stockholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share on Wednesday, July 27th. This represents a $0.84 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Friday, July 1st.
View Agilent Technologies' dividend history
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies(NYSE:A) pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.71%. Agilent Technologies has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Agilent Technologies is 20.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 15.56% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its board has initiated a stock repurchase program on Tuesday, February 16th 2021, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 5% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided EPS guidance of $4.86-$4.93 for the period, compared to the consensus EPS estimate of $4.60. The company issued revenue guidance of $6.67 billion-$6.73 billion, compared to the consensus revenue estimate of $6.36 billion.

Who are Agilent Technologies' key executives?

Agilent Technologies' management team includes the following people:

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies CEO Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among Agilent Technologies' employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

How do I buy shares of Agilent Technologies?

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $119.43.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $35.67 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $4.15 on an earnings per share basis.

How many employees does Agilent Technologies have?

Agilent Technologies employs 17,000 workers across the globe.

Does Agilent Technologies have any subsidiaries?

The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More

When was Agilent Technologies founded?

Agilent Technologies was founded in 1999.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for Agilent Technologies is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at [email protected], or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.